Open-Angle Glaucoma And Glaucoma Filtration Surgery

Open-Angle Glaucoma And Glaucoma Filtration Surgery Overview This population-based historic cohort study, spanning from 1997 to 2017, aimed to investigate the rate and risk factors associated with glaucoma filtration surgery (GFS) in individuals newly diagnosed with open-angle glaucoma (OAG) aged 45 and above. The cohort comprised 9420 patients diagnosed with OAG between

Retinal Nerve Fiber Wedge Defects In Glaucoma And Heart Disease

Retinal Nerve Fiber Wedge Defects In Glaucoma And Heart Disease The Study The study aimed to investigate the connection between localized vascular and retinal nerve fiber layer (RNFL) loss and an individual's genetic predisposition to both glaucoma and cardiovascular disease. Researchers used a statistical tool called polygenic risk scores (PRS) to assess

iStent Combination Therapy for Glaucoma and Cataracts

iStent Combination Therapy for Glaucoma and Cataracts Considering that glaucoma is the most common cause of irreversible vision loss and the third most common cause of vision loss worldwide, with cataracts and refractive error being the most prevalent causes, iStent combination therapy to treat glaucoma and cataracts has high therapeutic value. 

Open-Angle Glaucoma And Glaucoma Filtration Surgery